* This study evaluates the detection rates of high-risk HPV16 and HPV18 E6 oncoproteins in urine, vaginal self-collected, and cervical samples from 124 women using the OncoE6™ Cervical Test alongside HPV DNA testing.
* Findings show HPV16/18-E6 oncoprotein was found in 30.6% of cervical samples, but it had low detection in cases of CIN2 and CIN3, suggesting the test's clinical sensitivity is higher for invasive lesions, indicating a need for improved